International Seaways Amends Retiree Health Plan

International Seaways has announced amendments to its Retiree Health and Welfare Plan, effective January 1, 2017. The plan provides health and welfare benefits to eligible retirees of the company or its parent, International Seaways, Inc., and their eligible dependents. The plan covers only retired employees who meet specific eligibility and participation requirements and provides benefits to retirees who accrued under the OSG Ship Management, Inc. Retiree Health and Welfare Plan.

Under the eligibility criteria, retirees must have been hired by Overseas Shipholding Group, Inc. or its affiliates prior to January 1, 2005, and enrolled in the medical plan for active employees sponsored by the company or its affiliates or co-employers, or for active employees sponsored by OSG. They must also meet specific age and service requirements at the time of retirement. The plan also provides a $10,000 death benefit for eligible retirees.

The plan offers coverage through a Health Reimbursement Arrangement (HRA) account, which reimburses eligible retirees for certain medical and health expenses up to the amount available in the account. The HRA account is a bookkeeping account on the company's records, not funded, and does not bear interest or accrue earnings. It is credited with company contributions and debited for reimbursements to retirees for eligible medical expenses.

The amendments include details about eligible medical expenses, such as physician, hospital, dental, vision, and pharmacy expenses, among others. The plan also outlines the process for enrollment, coverage options, and the administration of benefits.

These amendments reflect the company's commitment to providing comprehensive health and welfare benefits to its eligible retirees and their dependents. Today the company's shares have moved 2.1% to a price of $36.7. For the full picture, make sure to review International Seaways's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS